Status:
COMPLETED
Psychotherapy of Anxiety Disorders With Noninvasive Brain Stimulation - Using Virtual Reality
Lead Sponsor:
Wuerzburg University Hospital
Collaborating Sponsors:
University of Wuerzburg
Conditions:
Phobia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to transfer the rTMS stimulation protocol by Raij et al. (2018) into a therapeutic setting to improve exposure therapy in acrophobic patients. The quasi-randomized, placebo-con...
Detailed Description
The following hypotheses are derived: 1. Patients with acrophobia, who receive an active rTMS of the left FC before VRET, show a significantly stronger reduction of phobic symptoms immediately after ...
Eligibility Criteria
Inclusion
- Acrophobia (according to DSM-5)
- Right handed
- German native speaker
- Written informed consent
Exclusion
- Neurological and/or severe physical illnesses
- Comorbid Axis I disorder (other than phobias)
- Pretreated phobia of heights
- Use of tricyclic antidepressants, antipsychotics, or other substances that increase cerebral seizure susceptibility
- Craniocerebral injuries, head surgery
- Epileptic seizures, or family history of epilepsy
- Metal parts in the head area
- Cardiac pacemakers
- Infusion pumps
- Heart diseases
- Increased intracranial pressure
- Pregnancy
- Cochlear implants
- Tattoos (done before the year 2000)
- Piercings (if not completely removable)
- Permanent make-up
- Nicotine or pain patches
- other MRI contraindications
Key Trial Info
Start Date :
May 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04782570
Start Date
May 12 2021
End Date
April 28 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Martin J. Herrmann
Würzburg, Germany, 97080